How Has the Mammalian Cell Fermentation Technology Market Evolved Historically and What is its Current Size?
The mammalian cell fermentation technology market has seen considerable growth due to a variety of factors.
• The mammalian cell fermentation technology market has expanded rapidly in recent years. It will increase from $51.29 billion in 2024 to $57.48 billion in 2025, at a CAGR of 12.1%.
The growth is driven by the demand for biologics and biosimilars, a focus on personalized medicine, increased biopharmaceutical output, and the need for scalable cell culture methods.
What Does Future Hold for The Mammalian Cell Fermentation Technology Market By 2029?
The mammalian cell fermentation technology market is expected to maintain its strong growth trajectory in upcoming years.
• The mammalian cell fermentation technology market is expected to reach $89.54 billion by 2029 with a CAGR of 11.7%.
Growth is driven by the rising prevalence of chronic diseases, investments in biotechnology, and the growing need for cancer therapies. Key trends include advancements in cell culture, bioreactor design, next-generation bioprocessing technologies, multi-omics approaches, and technology-driven automation.
What Are The Primary Growth Drivers In The Mammalian Cell Fermentation Technology Market?
The increasing demand for biologics is expected to drive the growth of the mammalian cell fermentation technology market. Biologics are derived from living organisms and are used to treat diseases like cancer and autoimmune disorders. The demand for biologics is rising due to advancements in biotechnology, regulatory approvals, and increased investment in research. Mammalian cell fermentation technology helps produce biologics at scale, driving innovation in the biopharmaceutical industry. For example, the National Library of Medicine reported in February 2024 that the FDA approved 55 new drugs in 2023, including 25 new biological entities. The growing demand for biologics is expected to boost the mammalian cell fermentation technology market.
What Is The Segmentation Of The Global Mammalian Cell Fermentation Technology Market?
The mammalian cell fermentation technology market covered in this report is segmented –
1) By Type: Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation, Other Types
2) By Application: Monoclonal Antibodies, Recombinant Proteins, Vaccines, Hormones, Enzymes, Other Applications
3) By End-Use: Biopharmaceutical Companies, Contract Research Organizations And Contract Development and Manufacturing Organizations, Academic And Research Institutes
Pre-Book The Mammalian Cell Fermentation Technology Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Mammalian Cell Fermentation Technology Market?
Leading businesses in the mammalian cell fermentation technology market are actively innovating, with a specific emphasis on mammalian cell culture techniques, in order to solidify their market standing. The mammalian cell culture technique is pivotal in several sectors, such as biomanufacturing, scientific research, and regenerative medicine given its utility in creating therapeutic proteins, vaccines, and functional cells or tissue substitutes. For instance, in June 2024, Syntegon, a biotech firm based in Germany, debuted its Modular Bioprocessing Platform (MBP) at Achema 2024, which was specifically engineered to address the main issues in biopharmaceutical manufacturing. This pioneering platform affords a highly adaptable, fully integrated, and automated solution that can be utilized for a myriad of applications, which include microbial and mammalian cell cultures, proteins, peptides, oligonucleotides, plasmid DNA, and recombinant vaccines. The modular structure of the MBP results in shorter lead times and lower costs while retaining superior functionality and quality, consistent with the "made in Germany" standard. The prefabricated design of the cleanroom situates all supplementary technology outside the cleanroom, improving efficiency and making maintenance easier.
Who Are the Key Players In The Mammalian Cell Fermentation Technology Market?
Major companies operating in the mammalian cell fermentation technology market are:
• AbbVie Inc.
• Thermo Fisher Scientific Inc
• AstraZeneca PLC
• Roche Holdings Inc.
• Merck KGaA
• AGC Group
• Lonza Group Ltd.
• Boehringer Ingelheim GmbH
• Catalent Inc.
• Sartorius AG
• Samsung Biologics Co. Ltd.
• WuXi Biologics
• Biocon Limited
• Eppendorf AG
• KBI Biopharma Inc.
• Fujifilm Diosynth Biotechnologies
• Avid Bioservices Inc.
• BiOZEEN
• Nordmark Pharma GmbH
• Scorpius BioManufacturing Inc
What Are The Regional Insights Into The Mammalian Cell Fermentation Technology Market?
North America was the largest region in the mammalian cell fermentation technology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mammalian cell fermentation technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
